Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2023

Apr 4, 2023

32485_dirs_2023-04-04_79567e5b-5d6a-4c80-be80-a2cfff5c329a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2023-03-31

Reporting Person: Cowen Aaron (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-31 Class A ordinary shares J 3087000 Disposed 3193175 Indirect
2023-03-31 Class A ordinary shares J 857500 Acquired 4050675 Indirect

Footnotes

F1: See Exhibit 99.1

F2: See Exhibit 99.1

F3: See Exhibit 99.1

F4: See Exhibit 99.1